Design
Review
Authors
Loading...
May facilitate precise titration in acute settings; leaves open randomized comparisons to longer-acting agents.
Esmolol's ultra-short duration of action makes it highly titratable and ideal for patients requiring carefully modulated beta blockade.
Reynolds et al. (1986) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: